Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 Next >
What's next for the Biden administration's Medicare drug price negotiations
Tags Pharmaceuticals US: News Bristol/Myers Squibb Co
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Johnson & Johnson US: News Health care industry
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Healthy Returns Biotech and Pharmaceuticals Abbvie Inc
From CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Tags Earnings Biotechnology Business
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Novo Nordisk A/S Merck & Co Inc Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Coca/Cola Co General Motors Co Tesla Inc
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Tags Layoffs COVID/19 Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
Tags Stock Picks Investment strategy Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Bristol/Myers Squibb Co Johnson & Johnson Eli Lilly and Co
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Great Lakes Dredge & Dock Corp U/S/ Markets Stock markets
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Investing Eli Lilly and Co Pro: Investing trends
From CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
Tags Bristol/Myers Squibb Co Johnson & Johnson US: News
From CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Tags Earnings Biotechnology Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News International Business Machines Corp Exxon Mobil Corp
From CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
Tags Science Health & Science Health care industry
From CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
Tags Health care industry Companies Health & Science
From CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
Tags Eli Lilly and Co Pharmaceuticals US: News
From CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
Tags Business News Politics Merck & Co Inc
From CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
Tags Companies Health & Science Health care industry
From CNBC.com News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Tags Business Biotechnology Earnings
From CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Tags Health & Science Health care industry Merck & Co Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Johnson & Johnson Investment strategy Advanced Micro Devices Inc
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Business News Merck & Co Inc Business
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Business News Novo Nordisk A/S Merck & Co Inc
From CNBC.com News
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
Tags Business RayzeBio Inc Business News
From CNBC.com News
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
Tags Mad Money JPMORGAN DRN U/S/ Markets
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags JPMORGAN DRN Mad Money Investment Strategy
From CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
Tags Amerisourcebergen Corp Business News Novartis AG
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Novartis AG Breaking news AstraZeneca PLC
From CNBC.com News
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Tags US: News Goldman Sachs Group Inc Bristol/Myers Squibb Co
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.